Cannabidiol in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension study
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cannabidiol in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension study
Authors
Keywords
-
Journal
EPILEPSIA
Volume 60, Issue 3, Pages 419-428
Publisher
Wiley
Online
2019-02-11
DOI
10.1111/epi.14670
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
- (2018) Elizabeth A Thiele et al. LANCET
- Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome
- (2018) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term retention rates for antiepileptic drugs: A review of long-term extension studies and comparison with brivaracetam
- (2017) Manuel Toledo et al. EPILEPSY RESEARCH
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
- (2017) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome
- (2017) Joshua S. Kaplan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Expert Opinion on the Management of Lennox–Gastaut Syndrome: Treatment Algorithms and Practical Considerations
- (2017) J. Helen Cross et al. Frontiers in Neurology
- Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
- (2016) Orrin Devinsky et al. LANCET NEUROLOGY
- Long-term prognosis of patients with Lennox–Gastaut syndrome in recent decades
- (2015) Hyo Jeong Kim et al. EPILEPSY RESEARCH
- Efficacy and safety of lacosamide as first add-on or later adjunctive treatment for uncontrolled partial-onset seizures: A multicentre open-label trial
- (2015) Wendy Waldman Zadeh et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Stable dosages of clobazam for Lennox-Gastaut syndrome are associated with sustained drop-seizure and total-seizure improvements over 3 years
- (2014) Joan A. Conry et al. EPILEPSIA
- Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
- (2014) Orrin Devinsky et al. EPILEPSIA
- Determining minimally important change thresholds for the Seizure Severity Questionnaire (SSQ)
- (2013) Joyce A. Cramer et al. EPILEPSY & BEHAVIOR
- Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures
- (2012) Nicholas A. Jones et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome
- (2011) Y. T. Ng et al. NEUROLOGY
- Childhood Epileptic Encephalopathy with Diffuse Slow Spike-Waves (otherwise known as “Petit Mal Variant”) or Lennox Syndrome
- (2010) H. GASTAUT et al. EPILEPSIA
- Cannabidiol Displays Antiepileptiform and Antiseizure Properties In Vitro and In Vivo
- (2009) N. A. Jones et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Clobazam in the treatment of Lennox-Gastaut syndrome
- (2008) Joan A. Conry et al. EPILEPSIA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started